Irvine-based cancer diagnostics firm Helio Genomics has announced its appointment of Dr. Bharat Tewarie as its new chief executive.
Current CEO Justin Chen Li, a founding member of the company, will remain at Helio as president.
“Leading Helio through its growth journey has been the honor of a lifetime,” Li said in a statement. “I’m excited to welcome Bharat, whose deep expertise and bold vision will be valuable as we enter our next chapter.”
Li has been CEO of the company since 2021. He previously served as the company’s vice president of finance and business development and general manager.
